Citius Share Price

Citius Share Price

NASDAQ: CTXR | Healthcare
$0.51
+$0.02 (3.06%) Last updated on 21 Nov, 2026 | 02:00 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Citius Stock Performance

Open
$0.51
Prev. Close
$0.49
Circuit Range
N/A
Day Range
$0.51 - $0.51
Year Range
$0.37 - $1.53
Volume
112
Average Traded
$0.51

Citius Share Price Today

As of 22 November 2026, Citius Pharmaceuticals, Inc.'s share price is $0.51. The stock opened at $0.51, compared to its previous close of $0.49. During today's trading session, Citius Pharmaceuticals, Inc.'s share price traded between $0.51 and $0.51, with an average price of $0.51. Over the past 52 weeks, the stock has recorded a high of $1.53 and a low of $0.37. In terms of performance, Citius Pharmaceuticals, Inc.'s share price has declined by 23.48% over the last six months and is down 64.47% on a year-on-year basis.

Citius Share Price Chart

Line chart of the Citius price trend over the selected period. The price rose overall, ranging from 0.50 to 0.51, ending at 0.51.
$0.51$0.51
L
Show Current Price
H

Citius Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.69
Revenue (TTM)
$0.00
Return On Equity (TTM)
-69.47%
Profit Margin
N/A
Debt to Equity
0.10
Quarterly Earnings Growth YoY
-11.31%

Citius Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$3.94$1.67$1.49
Net Profit-$7.96-$8.22-$21.23-$8.86
Net Profit MarginN/A-208.63%-1271.26%-594.63%
Income ChangeN/A-3.27%-158.27%58.27%

Citius Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$33.64-$33.69-$40.19-$37.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.15%-19.29%6.87%

Citius Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets103.0102.4369.2469.44
Current Assets27.9314.2234.3744.56
Total Assets130.94116.65103.61114.0
Non Current Liabilities8.56.746.46.04
Current Liabilities44.9135.815.784.53
Total Liabilities53.4142.5512.1810.57
Shareholders' Equity77.5374.191.43103.43

Citius Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-26.55-28.2-29.06-28.36
Investing-5.75-5.00.00.0
Financing33.39.9713.830.0

Corporate Actions

Split
Ex-date: 26 Nov 2024

About Citius

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Citius Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.55
$0.51
-6.96%
Oct 2026
$0.54
$0.55
-0.91%
Sep 2026
$0.58
$0.55
-10.26%
Aug 2026
$0.59
$0.61
+7.72%
Jul 2026
$0.62
$0.57
-2.40%
Jun 2026
$0.63
$0.58
-12.05%
May 2026
$0.69
$0.66
-3.07%
Apr 2026
$0.85
$0.69
-24.64%
Mar 2026
$0.72
$0.91
+24.01%
Feb 2026
$0.74
$0.73
-1.08%
Jan 2026
$0.79
$0.74
-3.14%
Dec 2025
$1.39
$0.77
-46.50%

Citius Share Price FAQs